... We Welcome You To The Resverlogix HUB On AGORACOM!

**Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial (now fully enrolled) and Will Soon Begin Phase 2 Kidney Dialysis and Fabry Disease Trials**


BREAKING: Good Life Networks Inc. increases second quarter revenue year over year by 123% to $3,435,835

  • Q2 revenue increased 123% to $3,435,835 from same quarter last year
  • Reported net income of $252,712, compared to a net loss of $353,632 in the same quarter last year
  • “Our year over year revenue growth for the second quarter was exceptional and further supports our projected revenue and earnings objectives for the full fiscal year,” said Jesse Dylan, GLN President and CEO

Glnlogo black 11

Hub On AGORACOM / Read Release


Message: Now is the time over late spring and summer


I doubt that there will be a cone of silence for too much longer. As I posted yesterday, the SSRA/FA at 75% of events is a huge inflection point. Assuming that the interim analysis is positive (best case scenario trial continues with no changes), then I expect management to shout from the hilltops. I agree, it would be great to have a conference call with Q&A. BIO International coming up in exactly 3 weeks is an opportunity. But probably not too much to be said if the SSRA still hasn't been triggered by then. 


New Message
Please login to post a reply